Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial

Fan Yang, Xiaofang Zheng, Sarene Koh, Jianxi Lu, Jintao Cheng, Panlong Li, Cong Du, Yunhao Chen, Xiaoyan Chen, Li Yang, Wanxin Chen, Regina Wanju Wong, Lu‐En Wai, Tingting Wang, Qi Zhang, Wenjie Chen